Breaking News Instant updates and real-time market news.

HTGC

Hercules Capital

$15.71 /

+0.49 (+3.22%)

16:11
02/20/20
02/20
16:11
02/20/20
16:11

Hercules Capital reports Q4 NII 38c, conseensus 36c

"In fiscal year 2019, Hercules Capital's outstanding operating performance set new records across many of its key financial and performance metrics, all of which were attributable to the Company's preeminent position in the venture and growth stage lending markets and our seasoned and disciplined investment team that possesses unparalleled domain experience in its core verticals," stated Scott Bluestein, chief executive officer and chief investment officer of Hercules. "Total fourth quarter commitments increased nearly 14 percent to $283.9 million, core yields were within management's targeted range of 12 to 13 percent, credit quality remained high and the debt investment portfolio expanded to $2.17 billion at cost. Hercules' 2019 performance also enabled the Company to declare record total shareholder distributions in 2019. Our record fourth quarter NII produced 119% coverage of our base shareholder distribution which combined with our record undistributed earnings spillover, puts us in a position of strength moving into 2020."

  • 20

    Feb

  • 10

    Mar

HTGC Hercules Capital
$15.71 /

+0.49 (+3.22%)

11/04/19 Wells Fargo
Hercules Capital benefiting from 'robust' venture debt market, says Wells Fargo
11/04/19 Wells Fargo
Hercules Capital upgraded to Outperform from Market Perform at Wells Fargo
05/06/19
Hercules Capital downgraded to Market Perform on valuation at Wells Fargo
05/06/19 Wells Fargo
Hercules Capital downgraded to Market Perform from Outperform at Wells Fargo

TODAY'S FREE FLY STORIES

Recommendations
K+S AG price target lowered to EUR 5 from EUR 8 at Morgan Stanley » 13:26
03/30/20
03/30
13:26
03/30/20
13:26
KPLUY

K+S AG

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Second Sight to wind down operations » 13:25
03/30/20
03/30
13:25
03/30/20
13:25
EYES

Second Sight

$2.32 /

+0.015 (+0.65%)

Second Sight announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Johnson Matthey price target cut to 2,900 GBp from 3,700 GBp at Morgan Stanley » 13:25
03/30/20
03/30
13:25
03/30/20
13:25
JMPLY

Johnson Matthey

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
LHC Group participates in a conference call with SunTrust » 13:25
03/30/20
03/30
13:25
03/30/20
13:25
LHCG

LHC Group

$133.77 /

+9.67 (+7.79%)

Healthcare Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Cowen tobacco/cannabis analyst to hold an analyst/industry conference call » 13:25
03/30/20
03/30
13:25
03/30/20
13:25
KERN

Akerna

$5.00 /

-0.18 (-3.47%)

Tobacco/Cannabis Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
Conference/Events
Wolfe Research leisure analysts to hold an analyst/industry webcast » 13:25
03/30/20
03/30
13:25
03/30/20
13:25

Consumer Products Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Roth Capital biotech analyst to hold an analyst/industry conference call » 13:25
03/30/20
03/30
13:25
03/30/20
13:25
ACER

Acer Therapeutics

$1.84 /

+ (+0.00%)

Biotech Analyst Rahimi,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Plains All American participates in a conference call with Wolfe Research » 13:25
03/30/20
03/30
13:25
03/30/20
13:25
PAGP

Plains GP Holdings

$5.30 /

-0.725 (-12.03%)

, PAA

Plains All American

$5.08 /

-0.46 (-8.30%)

Midstream Analyst Stanley…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Evonik price target lowered to EUR 27 from EUR 28 at Morgan Stanley » 13:24
03/30/20
03/30
13:24
03/30/20
13:24
EVKIF

Evonik

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Second Sight appoints Matthew Pfeffer as acting CEO » 13:24
03/30/20
03/30
13:24
03/30/20
13:24
EYES

Second Sight

$2.32 /

+0.015 (+0.65%)

Second Sight announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Elkem ASA price target lowered to NOK 17 from NOK 21 at Morgan Stanley » 13:22
03/30/20
03/30
13:22
03/30/20
13:22
ELKEF

Elkem ASA

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
DSM price target lowered to EUR 95 from EUR 104 at Morgan Stanley » 13:21
03/30/20
03/30
13:21
03/30/20
13:21
RDSMY

DSM

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Croda price target lowered to 5,000 GBp from 5,200 GBp at Morgan Stanley » 13:20
03/30/20
03/30
13:20
03/30/20
13:20
COIHY

Croda International

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Covestro price target lowered to EUR 40 from EUR 50 at Morgan Stanley » 13:19
03/30/20
03/30
13:19
03/30/20
13:19
COVTY

Covestro

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
BASF price target lowered to EUR 53 from EUR 63 at Morgan Stanley » 13:18
03/30/20
03/30
13:18
03/30/20
13:18
BASFY

BASF

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Arkema price target lowered to EUR 89 from EUR 107 at Morgan Stanley » 13:17
03/30/20
03/30
13:17
03/30/20
13:17
ARKAY

Arkema

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NASDAQ market internals summary » 13:17
03/30/20
03/30
13:17
03/30/20
13:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
AkzoNobel price target lowered to EUR 95 from EUR 100 at Morgan Stanley » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
AKZOY

AkzoNobel

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Technical Analysis
NYSE market internals summary » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Air Liquide price target lowered to EUR 115 from EUR 121 at Morgan Stanley » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
AIQUY

Air Liquide

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Second Sight to lay off approximately 84 of 108 employees » 13:16
03/30/20
03/30
13:16
03/30/20
13:16
EYES

Second Sight

$2.32 /

+0.015 (+0.65%)

Second Sight Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
CarMax Q4 will beat, but sales slowed in March, says William Blair » 13:11
03/30/20
03/30
13:11
03/30/20
13:11
KMX

CarMax

$56.57 /

-2.28 (-3.87%)

William Blair analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Oshkosh announces award of $346.4M in orders from Army » 13:09
03/30/20
03/30
13:09
03/30/20
13:09
OSK

Oshkosh

$60.66 /

+2.69 (+4.64%)

Oshkosh Defense, an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
St. James's Place downgraded to Equal Weight from Overweight at Morgan Stanley » 13:08
03/30/20
03/30
13:08
03/30/20
13:08
STJPF

St. James's Place

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Scor downgraded to Underweight from Equal Weight at Morgan Stanley » 13:07
03/30/20
03/30
13:07
03/30/20
13:07
SCRYY

Scor

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.